MolBreeding Biotech
PrivateLast Round
Series B
Jul 30, 2024
Total Funding Raised
$62.6M
Company Overview
MolBreeding Biotech is a biotechnology company that provides high-throughput genotyping services and molecular breeding solutions using its proprietary Genotyping by Targeted Sequencing (GBTS) technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Vertical SaaS
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MolBreeding Biotech Comps
Public and private peers based on sector, stage, and business model.
MolBreeding Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 30, 2024 | ||||
| Series A Extension | Feb 21, 2023 | ||||
| Series A Extension | Jun 13, 2022 | ||||
| Series A | Mar 24, 2021 |
MolBreeding Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Yunzhi Capital | Series A, Series A Extension |
| Lake Bleu Capital | Series B |
| Dalton Venture | Series B |
| Suzhou Guofa Venture Capital | Series B |
| Jiuyi Investment | Series B |
MolBreeding Biotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about MolBreeding Biotech's valuation, stock price, and market status.
